The promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection, a systematic review
Abstract Purpose Total hip and knee arthroplasty periprosthetic joint infection (PJI) poses a management dilemma owing to the emergence of resistant organisms. A promising option is Bacteriophage therapy (BT) was used as an adjuvant for PJI management, aiming at treating resistant infections, decrea...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Journal of Experimental Orthopaedics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40634-023-00586-z |
_version_ | 1827324282423738368 |
---|---|
author | Ahmed A. Khalifa Sarah M. Hussien |
author_facet | Ahmed A. Khalifa Sarah M. Hussien |
author_sort | Ahmed A. Khalifa |
collection | DOAJ |
description | Abstract Purpose Total hip and knee arthroplasty periprosthetic joint infection (PJI) poses a management dilemma owing to the emergence of resistant organisms. A promising option is Bacteriophage therapy (BT) was used as an adjuvant for PJI management, aiming at treating resistant infections, decreasing morbidity, and mortality. The current review aimed to demonstrate the role and safety of using BT as an adjuvant to treat PJIs. Methods A systematic search was performed through four databases (Embase, PubMed, Web of Science, and Scopus) up to March 2022, according to the predetermined inclusion and exclusion criteria. Results Our systematic review included 11 case reports of 13 patients in which 14 joints (11 TKAs and three THAs) were treated. The patients’ average age was 73.7 years, underwent an average of 4.5 previous surgeries. The most common organism was the Staphylococcus aureus species. All patients underwent surgical debridement; for the 13 patients, eight received a cocktail, and five received monophage therapy. All patients received postoperative suppressive antibiotic therapy. After an average follow‐up of 14.5 months, all patients had satisfactory outcomes. No recurrence of infection in any patient. Transaminitis complicating BT was developed in three patients, needed stoppage in only one, and the condition was reversible and non‐life‐threatening. Conclusion BT is a safe and potentially effective adjuvant therapy for treating resistant and relapsing PJIs. However, further investigations are needed to clarify some BT‐related issues to create effective and reproducible therapeutics. Furthermore, new ethical regulations should be implemented to facilitate its widespread use. |
first_indexed | 2024-03-08T04:58:00Z |
format | Article |
id | doaj.art-f5e038ade2624910acae54fd6d1c7ab0 |
institution | Directory Open Access Journal |
issn | 2197-1153 |
language | English |
last_indexed | 2024-04-25T02:10:12Z |
publishDate | 2023-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Experimental Orthopaedics |
spelling | doaj.art-f5e038ade2624910acae54fd6d1c7ab02024-03-07T12:46:41ZengWileyJournal of Experimental Orthopaedics2197-11532023-01-01101n/an/a10.1186/s40634-023-00586-zThe promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection, a systematic reviewAhmed A. Khalifa0Sarah M. Hussien1Orthopaedic DepartmentQena Faculty of Medicine and University HospitalSouth Valley UniversityKilo 6 Qena‐Safaga Highway83523QenaEgyptQena Faculty of MedicineSouth Valley UniversityQenaEgyptAbstract Purpose Total hip and knee arthroplasty periprosthetic joint infection (PJI) poses a management dilemma owing to the emergence of resistant organisms. A promising option is Bacteriophage therapy (BT) was used as an adjuvant for PJI management, aiming at treating resistant infections, decreasing morbidity, and mortality. The current review aimed to demonstrate the role and safety of using BT as an adjuvant to treat PJIs. Methods A systematic search was performed through four databases (Embase, PubMed, Web of Science, and Scopus) up to March 2022, according to the predetermined inclusion and exclusion criteria. Results Our systematic review included 11 case reports of 13 patients in which 14 joints (11 TKAs and three THAs) were treated. The patients’ average age was 73.7 years, underwent an average of 4.5 previous surgeries. The most common organism was the Staphylococcus aureus species. All patients underwent surgical debridement; for the 13 patients, eight received a cocktail, and five received monophage therapy. All patients received postoperative suppressive antibiotic therapy. After an average follow‐up of 14.5 months, all patients had satisfactory outcomes. No recurrence of infection in any patient. Transaminitis complicating BT was developed in three patients, needed stoppage in only one, and the condition was reversible and non‐life‐threatening. Conclusion BT is a safe and potentially effective adjuvant therapy for treating resistant and relapsing PJIs. However, further investigations are needed to clarify some BT‐related issues to create effective and reproducible therapeutics. Furthermore, new ethical regulations should be implemented to facilitate its widespread use.https://doi.org/10.1186/s40634-023-00586-zBacteriophage therapyPeriprosthetic infectionTotal hip arthroplastyTotal knee arthroplasty |
spellingShingle | Ahmed A. Khalifa Sarah M. Hussien The promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection, a systematic review Journal of Experimental Orthopaedics Bacteriophage therapy Periprosthetic infection Total hip arthroplasty Total knee arthroplasty |
title | The promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection, a systematic review |
title_full | The promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection, a systematic review |
title_fullStr | The promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection, a systematic review |
title_full_unstemmed | The promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection, a systematic review |
title_short | The promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection, a systematic review |
title_sort | promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection a systematic review |
topic | Bacteriophage therapy Periprosthetic infection Total hip arthroplasty Total knee arthroplasty |
url | https://doi.org/10.1186/s40634-023-00586-z |
work_keys_str_mv | AT ahmedakhalifa thepromisingroleofbacteriophagetherapyinmanagingtotalhipandkneearthroplastyrelatedperiprostheticjointinfectionasystematicreview AT sarahmhussien thepromisingroleofbacteriophagetherapyinmanagingtotalhipandkneearthroplastyrelatedperiprostheticjointinfectionasystematicreview AT ahmedakhalifa promisingroleofbacteriophagetherapyinmanagingtotalhipandkneearthroplastyrelatedperiprostheticjointinfectionasystematicreview AT sarahmhussien promisingroleofbacteriophagetherapyinmanagingtotalhipandkneearthroplastyrelatedperiprostheticjointinfectionasystematicreview |